期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 126, 期 4, 页码 1512-1524出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI83908
关键词
-
资金
- Dutch Organization for Scientific Research (NWO) [40-00812-98-11005]
- Fonds NutsOhra [SNO-T-08-32]
- Phelps Foundation [2011.040]
- Optimix Foundation for Scientific Research
- ZonMw VIDI research grant [91712343]
- Royal Dutch Academy of Arts and Sciences (KNAW) Van Leersumfonds
Vanishing white matter (VWM) is a fatal leukodystrophy that is caused by mutations in genes encoding subunits of eukaryotic translation initiation factor 213 (eIF2B). Disease onset and severity are codetermined by genotype. White matter astrocytes and oligodendrocytes are almost exclusively affected; however, the mechanisms of VWM development remain unclear. Here, we used VWM mouse models, patients' tissue, and cell cultures to investigate whether astrocytes or oligodendrocytes are the primary affected cell type. We generated 2 mouse models with mutations (Eif2b5(Arg191His/Ar191His) and Eif2b4(Arg484Trp/Arg484Trp)) that cause severe VWM in humans and then crossed these strains to develop mice with various mutation combinations. Phenotypic severity was highly variable and dependent on genotype, reproducing the clinical spectrum of human VWM. In all mutant strains, impaired maturation of white matter astrocytes preceded onset and paralleled disease severity and progression. Bergmann glia and retinal Muller cells, nonforebrain astrocytes that have not been associated with VWM, were also affected, and involvement of these cells was confirmed in VWM patients. In coculture, VWM astrocytes secreted factors that inhibited oligodendrocyte maturation, whereas WT astrocytes allowed normal maturation of VWM oligodendrocytes. These studies demonstrate that astrocytes are central in VWM pathomechanisms and constitute potential therapeutic targets. Importantly, astrocytes should also be considered in the pathophysiology of other white matter disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据